• Laila 28 soft capsules
1 1

Dr. Willmar Schwabe

Laila 28 soft capsules

Laila 28 soft capsules

€24,09
€25,90 €24,09
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

28ct

EAN

044460020

MINSAN

044460020

View full details

In compliance with article 118 "authorization of advertising to the public" of the legislative decree of 24 April 2006, number 219

INDICATIONS

Laila is a traditional medicine of plant origin indicated for the relief of mild anxiety symptoms and to promote sleep. The use of this traditional medicinal product of plant origin, for the indicated therapeutic indications, is based exclusively on many years of experience of use. Laila It is indicated in adults and adolescents aged 12 and over.

CONTRAINDICATIONS

Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.

WARNINGS AND PRECAUTIONS FOR USE

Use in children under 12 years has not been established due to insufficient data. If symptoms worsen during use of the product, a doctor or qualified healthcare professional should be consulted. Laila contains sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine. Use in patients with impaired liver function is not recommended since the components of lavender essence are largely eliminated by liver metabolism.

INTERACTIONS

Published data demonstrate that in humans lavender essential oil (160 mg/day) has no clinically relevant effects of inhibition or induction of CYP 1A2, 2C9, 2C19, 2D6 and 3A4 enzymes. Furthermore, no clinically relevant impact of lavender essential oil on the contraceptive efficacy of combined oral contraceptives has emerged.

SIDE EFFECTS

Gastrointestinal disorders Mild gastrointestinal discomfort (e.g. belching). Frequency not known. Skin and subcutaneous tissue disorders / Immune system disorders Allergic skin reactions. Frequency not known. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at http://www.agenziafarmaco.gov.it/content/come-segnalare-unasospetti-reazione-avversa.

OUR PRODUCTS FOR THIS SEASON

1 10
View all
1 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.